Report Description:

Global Prosthetic Heart Valve Market was valued at $3,874 million in 2016, and is expected to reach at $8,392 million by 2023, growing at a CAGR of 11.4%. Prosthetic heart valve is a device implanted in a patient suffering from valvular heart disease, which results in malfunction of one or more valves (out of a total four valves) present in the human heart. The treatment for such disease includes replacement of a natural heart valve with a prosthetic heart valve.

Browse Full Report here: http://www.acutemarketreports.com/report/prosthetic-heart-valve-market-report

Rise in prevalence of cardiac disorders, such as rheumatic heart diseases, increase in geriatric population, change in lifestyle of people, novel technological advancements in prosthetic heart valves, increase in patient awareness, demand for minimally invasive cardiovascular surgeries, and rise in number of transcatheter heart valve surgery centers drive the market growth. However, high cost and risk associated with prosthetic heart valves and stringent approval process (as formulated by FDA and other regulatory bodies) for prosthetic heart valves restrain the market growth. The growth opportunities in emerging countries of Asia-Pacific and LAMEA and use of transcatheter heart valves for new indications (treatment of intermediate-risk patients and high risk patients) are expected to provide numerous opportunities for the market growth during the forecast period.

Segment Review

The transcatheter heart valve segment accounted for the highest market share in 2016, due to rise in prevalence of aortic stenosis and increase in geriatric population. In addition, rise in adoption rate for transcatheter heart valve implantation procedure and new device approvals are expected to lead the growth of transcatheter heart valve market. Moreover, use of transcatheter heart valves for new indications is a major opportunity for the market growth.

Browse All Reports of This Category: http://www.acutemarketreports.com/category/medical-equipments-market

Snapshot of Lamea Prosthetic Heart Valve Market

Rise in incidence of structural heart diseases and rapid adoption of prosthetic valves drive the growth of the prosthetic valves market in LAMEA. There is an increase in prevalence of cardiac disorders, such as aortic stenosis in the Latin America due to lack of efficient treatment systems in these countries. In addition, the Latin American countries have reduced gross income leading to less expenditure on the development of new methods and devices, resulting in increase in need for efficient treatment systems. This increase in demand has attracted several key players from the West to invest in the Brazilian market for the growth of their transcatheter heart valve business. Israel offers an emerging market for transcatheter heart valve implantation procedure, owing to increase in geriatric population and rise in demand for unmet treatment procedures, which boost the market growth. Lack of facilities and an increased need for treatment devices have drawn the key players to invest in the Middle Eastern market.

Clinical trials

The prosthetic valves market has witnessed several clinical trials in the recent years. Transcatheter valves accounted for the highest number of clinical trials in the market, owing to their high durability and lower requirement for anticoagulation therapy. The European countries conduct maximum number of clinical trials as a result of high prevalence of heart diseases, such as aortic stenosis and mitral regurgitation. For instance, in Europe, more than 1.75 million people suffer from aortic stenosis. In addition, mechanical valves trials were highest in Europe (about 45.6%) followed by North America (38.1%).

The list of key players profiled in this report include Abbott Laboratories, Medtronic plc., Medical Technology Est., Boston Scientific Corporation, Micro Interventional Devices, Inc., Direct Flow medical, Inc., Edwards Lifesciences Corporation, LivaNova PLC., JenaValve Technology, Inc., and Cryolife, Inc.

Key players in the value chain include Corvia Medical, Inc., CardioKinetix, Inc., Biomerics, LLC., Lepu Medical Technology (Beijing) Co., Ltd., XELTIS BV, Comed B.V., HLT, Inc., Meril Life Sciences Pvt. Ltd., SYMETIS SA, and Transcatheter Technologies GmbH.

Browse the complete report at: http://www.acutemarketreports.com/report/prosthetic-heart-valve-market-report

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis and comprehensive analysis of all geographical regions from 2016 to 2023, to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis by product helps understand the various types of devices used for the treatment and monitoring of the cardiac patients.
• Key players are profiled and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global market.

Table of Content:

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.2.3. Market share analysis, 2016

3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Rise in number of patients suffering from structural heart diseases
3.3.1.2. Technological advancements in heart valve replacement devices
3.3.1.3. Growth in demand for minimally invasive procedures
3.3.1.4. Increase in number of TAVR Centers
3.3.2. Restraints
3.3.2.1. High cost and risk associated with the treatment procedures
3.3.2.2. Stringent approval process for prosthetic heart valves
3.3.3. Opportunities
3.3.3.1. Lucrative opportunities in emerging economies
3.3.3.2. Use of transcatheter heart valves for new indications
3.3.4. Impact Analysis

3.4. GOVERNMENT REGULATIONS
3.5. REIMBURSEMENT SCENARIO
3.6. CLINICAL TRIALS

Chapter: 4 PROSTHETIC HEART VALVE MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Key market trends
4.1.2. Key growth factors and opportunities
4.1.3. Market size and forecast

4.2. MECHANICAL HEART VALVES
4.2.1. Key market trends
4.2.2. Market size and forecast

4.3. TISSUE HEART VALVES
4.3.1. Stented tissue heart valve
4.3.2. Stentless tissue heart valve
4.3.3. Key market trends
4.3.4. Market size and forecast

4.4. TRANSCATHETER HEART VALVES
4.4.1. Key market trends
4.4.2. Market size and forecast

Chapter: 5 PROSTHETIC HEART VALVE MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast

5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.
5.2.5. Canada
5.2.6. Mexico

5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany
5.3.5. France
5.3.6. UK
5.3.7. Italy
5.3.8. Spain
5.3.9. The Netherlands
5.3.10. Belgium
5.3.11. Switzerland
5.3.12. Russia
5.3.13. Denmark
5.3.14. Austria
5.3.15. Norway
5.3.16. Poland
5.3.17. Sweden
5.3.18. Rest of Europe

5.4. ASIA-PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan
5.4.5. China
5.4.6. India
5.4.7. Australia
5.4.8. Malaysia
5.4.9. Republic of Korea
5.4.10. New Zealand
5.4.11. Singapore
5.4.12. Thailand
5.4.13. Vietnam
5.4.14. Taiwan
5.4.15. Indonesia
5.4.16. Rest of Asia-Pacific market size and forecast

5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil
5.5.5. South Africa
5.5.6. Saudi Arabia
5.5.7. United Arab Emirates (UAE)
5.5.8. Libya
5.5.9. Algeria
5.5.10. Kenya
5.5.11. Kuwait
5.5.12. Jordan
5.5.13. Sudan
5.5.14. Morocco
5.5.15. Israel
5.5.16. Zimbabwe
5.5.17. Mauritius
5.5.18. Oman
5.5.19. Argentina
5.5.20. Iran
5.5.21. Iraq
5.5.22. Rest of LAMEA

Latest Reports:
http://www.acutemarketreports.com/report/stents-market-by-stents-type

http://www.acutemarketreports.com/report/ultrasound-devices-market-by-product

http://www.acutemarketreports.com/report/continuous-glucose-monitoring-systems-market-report
About – Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us:

Name : Chris Paul

ACUTE MARKET REPORTS

Designation : Global Sales Manager

Toll Free(US/CANADA): +1-855-455-8662

Email : sales@acutemarketreports.com

Website : http://www.acutemarketreports.com